[go: up one dir, main page]

NO930226L - Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater - Google Patents

Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater

Info

Publication number
NO930226L
NO930226L NO93930226A NO930226A NO930226L NO 930226 L NO930226 L NO 930226L NO 93930226 A NO93930226 A NO 93930226A NO 930226 A NO930226 A NO 930226A NO 930226 L NO930226 L NO 930226L
Authority
NO
Norway
Prior art keywords
preparations
cephalosporins
homologs
pharmaceutical
pharmaceutical preparations
Prior art date
Application number
NO93930226A
Other languages
English (en)
Norwegian (no)
Other versions
NO930226D0 (no
Inventor
John Hargreaves Bateson
George Burton
Stephen Christopher Marti Fell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of NO930226D0 publication Critical patent/NO930226D0/no
Publication of NO930226L publication Critical patent/NO930226L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO93930226A 1990-07-24 1993-01-22 Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater NO930226L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds
PCT/GB1991/001228 WO1992001696A1 (en) 1990-07-24 1991-07-22 Cephalosporins and homologues, preparations and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO930226D0 NO930226D0 (no) 1993-01-22
NO930226L true NO930226L (no) 1993-03-23

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930226A NO930226L (no) 1990-07-24 1993-01-22 Cefalosporiner og homologer, fremstillinger og farmasoeytiske preparater

Country Status (26)

Country Link
EP (2) EP0540606A1 (pt)
JP (2) JPH05509089A (pt)
KR (1) KR100189075B1 (pt)
CN (2) CN1061046C (pt)
AP (1) AP832A (pt)
AT (1) ATE185567T1 (pt)
AU (1) AU648329B2 (pt)
CA (2) CA2359744C (pt)
CZ (1) CZ6493A3 (pt)
DE (2) DE69131714T2 (pt)
DK (1) DK0540609T3 (pt)
ES (1) ES2137162T3 (pt)
FI (1) FI930270A (pt)
GR (1) GR3031711T3 (pt)
HU (1) HUT63628A (pt)
IE (1) IE912569A1 (pt)
IL (1) IL98909A0 (pt)
LU (1) LU91290I2 (pt)
MX (1) MX9100317A (pt)
MY (1) MY106399A (pt)
NL (1) NL300249I1 (pt)
NO (1) NO930226L (pt)
NZ (1) NZ239061A (pt)
PT (1) PT98426A (pt)
WO (2) WO1992001695A1 (pt)
YU (1) YU129691A (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
DE69331047T2 (de) * 1992-01-22 2002-03-21 Pfizer Inc., New York 2-isocephem und -oxacephemderivate,verfahren zu deren herstellung, deren zwischenprodukte und verwendung als antibakterielle mittel
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
WO1998014421A1 (fr) * 1996-10-02 1998-04-09 Daiichi Pharmaceutical Co., Ltd. Procede d'esterification de composes carboxyliques
FR2776292B1 (fr) 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) 2000-08-03 2000-09-27 Pfizer Novel process
JP2004515503A (ja) * 2000-12-04 2004-05-27 ファイザー・プロダクツ・インク セファロスポリン系抗生物質の製造のために有用な方法及びエステル誘導体
KR100526379B1 (ko) * 2000-12-04 2005-11-08 화이자 프로덕츠 인크. 세팔로스포린 제조에 유용한 커플링법 및 중간체
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
LT2794627T (lt) 2011-12-22 2019-01-10 Alios Biopharma, Inc. Pakeistieji nukleozidai, nukleotidai ir jų analogai
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
AP3545A (en) 2012-05-25 2016-01-14 Janssen Sciences Ireland Uc Uracyl spirooxetane nucleosides
EP2935303B1 (en) 2012-12-21 2021-02-17 Janssen BioPharma, Inc. 4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
EP3841123A2 (en) 2018-08-23 2021-06-30 Seagen Inc. Anti-tigit antibodies
UY38979A (es) 2019-12-06 2021-07-30 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
JP7429799B2 (ja) 2020-02-18 2024-02-08 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
CN114213433B (zh) * 2020-06-08 2023-03-24 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物的制备方法
EP4323362A1 (en) 2021-04-16 2024-02-21 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
KR20240031300A (ko) 2021-06-04 2024-03-07 버텍스 파마슈티칼스 인코포레이티드 나트륨 채널 조절제로서의 n-(하이드록시알킬 (헤테로)아릴) 테트라하이드로푸란 카르복스아미드
CA3228162A1 (en) 2021-08-18 2023-02-23 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
NL7305936A (pt) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
AP832A (en) 2000-05-03
DK0540609T3 (da) 1999-12-27
IE912569A1 (en) 1992-01-29
ATE185567T1 (de) 1999-10-15
KR100189075B1 (ko) 1999-06-01
KR930701456A (ko) 1993-06-11
HU9300177D0 (en) 1993-04-28
NL300249I2 (en) 2007-02-01
EP0540606A1 (en) 1993-05-12
ES2137162T3 (es) 1999-12-16
FI930270A0 (fi) 1993-01-22
CZ6493A3 (en) 1994-04-13
CN1111410C (zh) 2003-06-18
CN1061046C (zh) 2001-01-24
WO1992001696A1 (en) 1992-02-06
AU8222491A (en) 1992-02-18
YU129691A (sh) 1994-01-20
PT98426A (pt) 1992-05-29
IL98909A0 (en) 1992-07-15
MX9100317A (es) 1992-02-28
JPH05509305A (ja) 1993-12-22
AU648329B2 (en) 1994-04-21
JPH05509089A (ja) 1993-12-16
HUT63628A (en) 1993-09-28
NL300249I1 (nl) 2007-02-01
LU91290I2 (fr) 2007-01-22
EP0540609B1 (en) 1999-10-13
DE69131714D1 (de) 1999-11-18
AP9100305A0 (en) 1991-07-31
CA2359744C (en) 2007-02-13
EP0540609A1 (en) 1993-05-12
CA2087967C (en) 2002-09-10
DE122006000065I2 (de) 2007-09-13
FI930270A (fi) 1993-03-22
GR3031711T3 (en) 2000-02-29
DE69131714T2 (de) 2000-02-24
JP2851428B2 (ja) 1999-01-27
MY106399A (en) 1995-05-30
CA2087967A1 (en) 1992-01-25
DE122006000065I1 (de) 2007-03-01
NZ239061A (en) 1993-11-25
CN1223859A (zh) 1999-07-28
NO930226D0 (no) 1993-01-22
WO1992001695A1 (en) 1992-02-06
CN1060469A (zh) 1992-04-22
CA2359744A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
DK0540609T3 (da) Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
NO902658L (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
NO922005D0 (no) Farmasoeytiske preparater
NO922506L (no) Farmasoeytiske preparat
NO912589D0 (no) Anti-plakk og anti-tannsten tannpasta.
DK130389A (da) Catecholderivater og farmaceutiske praeparater omfatende samme
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK650089A (da) Furanalkylketoner og farmaceutiske praeparater deraf
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
NO912946D0 (no) P-acylaminofenoksikarbamater og derivater.
NO903675D0 (no) Aminfrie forestrede glycidyleter-addisjonsprodukter og anvendelse derav.
NO892676D0 (no) Sialinsyre-bundet oktapeptid og fremstilling derav.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO911298L (no) Farmasoeytisk preparat og anvendelse derav.
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
DK75791D0 (da) Novel pharmaceutical preparations
DK165976C (da) 5-aminosulfonyl-methyl-indolderivater og farmaceutiske praeparater med indhold deraf
NO901828L (no) Poroese polymerkuler og fremgangsmaate.